Hereditary hemorrhagic telangiectasia–related epistaxis: innovations in understanding and management

NB Sautter, TL Smith - International forum of allergy & rhinology, 2012 - Wiley Online Library
Background: Epistaxis is the most common manifestation of hereditary hemorrhagic
telangiectasia (HHT), affecting approximately 90% of patients at some point during their …

Persistent epistaxis: what is the best practice?

N Umapathy, A Quadri, DW Skinner - Rhinology, 2005 - europepmc.org
Epistaxis is the commonest otolaryngological emergency, which is often managed by a
nasal pack. A significant number of cases fail to respond to nasal packing and various …

The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study

S Dheyauldeen, M Abdelnoor… - American Journal of …, 2011 - journals.sagepub.com
Background Epistaxis is usually the first and most common symptom in hereditary
hemorrhagic telangiectasia (HHT), which is known also as Rendu-Osler-Weber syndrome …

Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients

F Pagella, A Colombo, E Matti… - American journal of …, 2009 - journals.sagepub.com
Background Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-
Weber syndrome, is an autosomal dominant disease that leads to multiregional …

Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia

G Jørgensen, B Lange, JH Wanscher… - European archives of oto …, 2011 - Springer
Earlier studies have shown the effect of laser treatment on epistaxis in patients with
hereditary hemorrhagic telangiectasia (HHT). At the present time, only very few prospective …

Transarterial embolization to control posterior epistaxis

JN Hicks, G Vitek - The Laryngoscope, 1989 - Wiley Online Library
Posterior nasal epistaxis is a challenging problem for the oto‐laryngologist, particularly
when patients are critically ill after significant blood loss. The purpose of this paper is to …

Recent trends in epistaxis management in the United States: 2008-2010

JA Villwock, K Jones - JAMA Otolaryngology–Head & Neck …, 2013 - jamanetwork.com
Importance The treatment of epistaxis is variable. It is important to analyze the effect of the
available interventions on patient outcomes. Objective To determine demographic …

Diagnosis and treatment of hereditary hemorrhagic telangiectasia

C Grigg, D Anderson, J Earnshaw - Ochsner Journal, 2017 - ochsnerjournal.org
Background: Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disorder known
for its debilitating symptoms. More than 90% of patients with HHT experience epistaxis, and …

[PDF][PDF] Hereditary haemorrhagic telangiectasia: state of the art

ML Fiorella, DA Ross, RI White, C Sabba… - Acta Otorhinolaryngol …, 2004 - actaitalica.it
Hereditary haemorrhagic teleangiectasia (HHT) or Rendu-Osler-Weber disease is a genetic
autosomal-dominant disorder characterised by the presence of vascular telangiectases in …

Medical treatment for epistaxis in hereditary hemorrhagic telangiectasia: a meta-analysis

YP Hsu, CW Hsu, CH Bai… - … –Head and Neck …, 2019 - journals.sagepub.com
Objectives The aim of this study (PROSPERO ID: CRD42017081952) was to evaluate
medical treatment for epistaxis from hereditary hemorrhagic telangiectasia (HHT). Data …